Dr. Sanjay G. Godara

Dr. David M. Systrom is a physician at Brigham and Women’s Hospital. He is also an assistant professor of medicine at Harvard Medical School.He received his medical degree from Dartmouth Medical School (now known as Geisel School of Medicine). He then completed a residency in internal medicine at Emory University Hospital, followed by a fellowship in internal medicine at Massachusetts General Hospital. He is board certified in internal medicine and pulmonary disease.An active investigator and director of the Massachusetts General Hospital Cardiopulmonary laboratory, Dr. Systrom regularly publishes research examining pulmonary hypertension, pulmonary vascular disease, right heart failure and thromboembolic disease. He has authored over 130 peer-reviewed publications, has received funding from the National Institutes of Health and the American Heart Association, and has been named to the annual list of the Best Doctors in America. Dr. Systrom is a member of the American Thoracic Society, the American Heart Association and the American Physiological Society. He has special expertise in the pathophysiology of exercise intolerance in ME/CFS and Long Covid and is conducting clinical trials investigating the same. Dr. Systrom is rated as an Advanced provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Hyperventilation, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is rated as a Distinguished provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.

William Stephan is a Pulmonary Medicine provider in Nashua, New Hampshire. Dr. Stephan is rated as an Advanced provider by MediFind in the treatment of Hyperventilation. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, and Asthma.